| TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis (NCT04380831) | City of Hope Medical Center | 2022-02-24 |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO (NCT03816345) | National Cancer Institute (NCI) | 2019-07-16 |
| Role of Eosinophil in Fibrogenesis of Systemic Sclerosis (NCT03816189) | University Hospital, Lille | 2018-10-03 |
| Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis (NCT03575156) | University Hospital, Bordeaux | 2018-09-20 |
| BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA (NCT03629002) | Assistance Publique Hopitaux De Marseille | 2018-09-01 |
| Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis (NCT03508375) | Assistance Publique Hopitaux De Marseille | 2018-05-15 |
| Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment (NCT03262922) | Rennes University Hospital | 2016-07-29 |
| Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial (NCT02349009) | Prism Pharma Co., Ltd. | 2015-06-01 |
| Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells (NCT02213705) | Assistance Publique - Hôpitaux de Paris | 2014-05-06 |
| Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease (NCT01559129) | Celgene | 2012-08-09 |
| Scleroderma Treatment With Autologous Transplant (STAT) Study (NCT01413100) | Fred Hutchinson Cancer Center | 2011-09-15 |
| Immunoadsorption in Patients With Severe Systemic Sclerosis (NCT01410903) | GWT-TUD GmbH | 2011-04-01 |
| Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease (NCT01309997) | Lee, Stephanie | 2011-03-01 |
| Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY (NCT01295736) | University Hospital, Lille | 2010-11-01 |
| Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis (NCT00628797) | Nicolas Hunzelmann | 2008-02-01 |
| CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study (NCT00522002) | George Washington University | 2007-08-01 |
| Cardiac Repercussion of Systemic Sclerodermias (NCT00697736) | Hospices Civils de Lyon | 2007-03-01 |
| Placebo Controlled Trial of Bosentan in Scleroderma Patients (NCT00377455) | Georgetown University | 2006-09-01 |
| Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis (NCT00622895) | Fred Hutchinson Cancer Center | 2006-09-01 |
| Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis (NCT00318175) | Heinrich-Heine University, Duesseldorf | 2006-06-01 |
| Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis (NCT00318188) | Assistance Publique - Hôpitaux de Paris | 2005-09-01 |
| Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma (NCT00278525) | Northwestern University | 2005-09-01 |
| Scleroderma Lung Disease (NCT00004563) | The University of Texas Health Science Center, Houston | 1999-08-01 |